SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange📊Experiments🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge💹Economics📊Experiments🤖Agents🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
📖

Section 174: Oligonucleotide Therapies (ASO/SSO) in CBS/PSP

wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-section-174-oligonucle
Related Entities
therapeutics-section-174-oligonucleotide-therapies-cbs-psp
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (270)
mentions🔬Epigenetic clocks and biological aging in neurodegeneration100%
mentions🔬Analysis question not specified100%
mentions🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br100%
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
mentions🧪Membrane Cholesterol Gradient Modulators70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
related🧫Brainstem Circuit Modulation for PSP70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Tau Pathology Initiation Zone Identification70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
mentions🧪Circadian-Synchronized LRP1 Pathway Activation70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫PSP and CBS Biomarker Validation Study70%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%
related🧫Cytochrome Therapeutics70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Tau Pathology Initiation Zone Identification70%
related🧫N-of-1 Clinical Trial Design for CBS/PSP70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Tau ASO Therapy70%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
related🧫4R-Tau Targeting Therapies for PSP and CBS70%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
related🧫4R-Tau Targeting Therapies for PSP and CBS70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming70%
related🧫PSP and CBS Biomarker Validation Study70%
related🧫Brainstem Circuit Modulation for PSP70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫N-of-1 Clinical Trial Design for CBS/PSP70%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
related🧫Cytochrome Therapeutics70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
related🧫Tau ASO Therapy70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides65%
related🧪Membrane Cholesterol Gradient Modulators63%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming63%
related🧪Circadian-Synchronized LRP1 Pathway Activation63%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp60%
mentions🔬PSP and CBD both involve 4R-tau but produce distinct neuropa60%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides59%
related🔬PSP and CBD both involve 4R-tau but produce distinct neuropa54%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp54%
see_also📖Japan Neurodegeneration Epidemiology50%
see_also📖mTOR Signaling in Neurodegeneration50%
see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration50%
see_also📖Neural Circuits in Neurodegeneration50%
see_also📖GDNF Signaling Pathway in Neurodegeneration50%
see_also📖PPAR Signaling Pathway in Neurodegeneration50%
see_also📖COVID-19 Neurodegeneration Mechanism50%
see_also📖NRF2 Signaling Pathway in Neurodegeneration50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
see_also📖Metabolomic Biomarkers in Neurodegeneration50%
see_also📖Disease Progression & Staging in Neurodegeneration50%
see_also📖Synaptic Biomarkers in Neurodegeneration50%
see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration50%
see_also📖Neurotensin Signaling in Neurodegeneration50%
see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread50%
see_also📖Sleep Dysfunction in Neurodegeneration50%
see_also📖China Neurodegeneration Epidemiology50%
see_also📖Tertiary Lymphoid Organs in Neurodegeneration50%
see_also📖Paranodal Dysfunction in Neurodegeneration50%
see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration50%
see_also📖Vagus Nerve Pathway in Neurodegeneration50%
see_also📖Mitochondrial Fusion in Neurodegeneration50%
see_also📖Protein Aggregation Comparison in Neurodegeneration50%
see_also📖Prion Protein Metabolism in Neurodegeneration50%
see_also📖mTOR Signaling Pathway in Neurodegeneration50%
see_also📖Endocannabinoid System in Neurodegeneration50%
see_also📖CaMKII Signaling Pathway in Neurodegeneration50%
see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration50%
see_also📖Ribosome Dysfunction in Neurodegeneration50%
see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener50%
see_also📖Histone Modification Pathways in Neurodegeneration50%
see_also📖Advanced Glycation End Products in Neurodegeneration50%
see_also📖Amylin Signaling in Neurodegeneration50%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%
see_also📖GDF15/GDF11 Signaling in Neurodegeneration50%
see_also📖Pericyte Loss in Neurodegeneration50%
see_also📖Hippocampal Neurogenesis in Neurodegeneration50%
see_also📖Glycosylation in Neurodegeneration50%
see_also📖Potential Impact Measures — Neurodegeneration50%
see_also📖Axon Guidance Pathways in Neurodegeneration50%
see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration50%
see_also📖Kidney-Brain Neurodegeneration Axis50%
see_also📖Prion-Like Spread in Neurodegeneration50%
see_also📖FA2H-Associated Neurodegeneration Pathway50%
see_also📖Nitric Oxide Signaling in Neurodegeneration50%
see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration50%
see_also📖PLA2G6-Associated Neurodegeneration (PLAN)50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
see_also📖Neuropil Threads in Neurodegeneration50%
see_also📖Cell-Free DNA Biomarkers in Neurodegeneration50%
related🧪R-Loop Resolution Enhancement Therapy50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration50%
see_also📖Neurovascular Unit Dysfunction in Neurodegeneration50%
see_also📖Metal Homeostasis Dysregulation in Neurodegeneration50%
see_also📖RNA Splicing in Neurodegeneration50%
see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 50%
see_also📖Endosomal Sorting Defects in Neurodegeneration50%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration50%
see_also📖epigenetics-neurodegeneration50%
see_also📖Serotonergic Dysfunction in Neurodegeneration50%
see_also📖MicroRNA Dysfunction in Neurodegeneration50%
see_also📖Neuroimaging Biomarkers for Neurodegeneration50%
see_also📖acetylcholine-signaling-neurodegeneration50%
see_also📖India Neurodegeneration Epidemiology50%
see_also📖Retinal Degeneration Pathway in Neurodegeneration50%
see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration50%
see_also📖Noradrenergic Signaling Pathway in Neurodegeneration50%
see_also📖Global Neurodegeneration Epidemiology50%
see_also📖RNA-Targeted Therapies in Neurodegeneration50%
see_also📖Economic Burden — Neurodegeneration50%
see_also📖interleukin-6-signaling-neurodegeneration50%
see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio50%
see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration50%
see_also📖Exosomal Biomarkers in Neurodegeneration50%
see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 50%
see_also📖Homocysteine Neurotoxicity and Neurodegeneration50%
see_also📖Protein Aggregation Seeds in Neurodegeneration50%
see_also📖R-Loop Stress in Neurodegeneration50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
see_also📖Galectin-3 Mechanism in Neurodegeneration50%
see_also📖PKR Pathway in Neurodegeneration50%
see_also📖Cortical Involvement and Neurodegeneration in Progressive Su50%
see_also📖Neuronal Hyperexcitability in Neurodegeneration50%
see_also📖IGF-1 Signaling Pathway in Neurodegeneration50%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi50%
see_also📖Microglial Priming Pathway in Neurodegeneration50%
see_also📖Autosis Pathway in Neurodegeneration50%
see_also📖IL-6 (Interleukin-6) in Neurodegeneration50%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and50%
see_also📖Parthanatos in Neurodegeneration50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain50%
see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
see_also📖Liquid Biopsy in Neurodegeneration50%
see_also📖P-Body (Processing Body) Pathway in Neurodegeneration50%
see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a50%
see_also📖Diffusion MRI (DTI) in Neurodegeneration50%
see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration50%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)50%
see_also📖Lipid Dysregulation in Neurodegeneration50%
see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration50%
see_also📖Copper Homeostasis in Neurodegeneration50%
see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr50%
see_also📖Therapeutic Targets in Neurodegeneration50%
see_also📖Senescent Cell Clearance in Neurodegeneration50%
see_also📖Cognitive Reserve and Resilience in Neurodegeneration50%
see_also📖Down Syndrome Neurodegeneration Pathway50%
see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 50%
mentions🧪APOE Isoform Conversion Therapy50%
see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)50%
see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration50%
see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)50%
see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat50%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration50%
see_also📖Digital Phenotyping in Neurodegeneration50%
see_also📖Computational Disease Models for Neurodegeneration50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau50%
see_also📖Purinergic Signaling in Neurodegeneration50%
see_also📖mitochondrial-dysfunction-neurodegeneration-comparison50%
see_also📖Familial vs Sporadic Neurodegeneration Comparison50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration50%
see_also📖Molecular Chaperones in Neurodegeneration50%
see_also📖Exosomal miR-155 in Neurodegeneration50%
see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration50%
see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
see_also📖Sex Differences in Neurodegeneration50%
see_also📖Short Chain Fatty Acids in Neurodegeneration50%
see_also📖Prion Diseases in Neurodegeneration50%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration50%
see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration50%
see_also📖Paraptosis in Neurodegeneration50%
mentions🧪Temporal Decoupling via Circadian Clock Reset50%
see_also📖NF-kB Signaling Pathway in Neurodegeneration50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
see_also📖Manganese-Related Neurodegeneration (Manganism)50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers50%
see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration50%
mentions🧫Tau depletion effects on neuronal development in primary cul50%
see_also📖Neuropeptide Y Signaling in Neurodegeneration50%
see_also📖Prognostic Biomarkers in Neurodegeneration50%
see_also📖Ghrelin Signaling Pathway in Neurodegeneration50%
see_also📖Convergent Pathways in Neurodegeneration50%
see_also📖Sigma-1 Receptor Signaling in Neurodegeneration50%
see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration50%
see_also📖Orexin Signaling in Neurodegeneration50%
see_also📖Cholinergic System Dysfunction in Neurodegeneration50%
see_also📖T-Cell Dysfunction in Neurodegeneration50%
see_also📖Metal Homeostasis in Neurodegeneration50%
mentions🧫Microtubule domain analysis in adult axons50%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration50%
see_also📖Endothelin Signaling Pathway in Neurodegeneration50%
see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen50%
see_also📖Progesterone Signaling Pathway in Neurodegeneration50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)50%
see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration50%
see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 50%
see_also📖Integrated Stress Response in Neurodegeneration50%
see_also📖Gangliosides in Neurodegeneration50%
see_also📖Dystrophic Neurites in Neurodegeneration50%
see_also📖HMGB1 Signaling in Neurodegeneration50%
see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati50%
see_also📖European Neurodegeneration Epidemiology50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration50%
see_also📖Sleep Disorders in Neurodegeneration50%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration50%
see_also📖S100 Protein Signaling Pathway in Neurodegeneration50%
see_also📖IL-1 Signaling Pathway in Neurodegeneration50%
see_also📖US Neurodegeneration Epidemiology50%
see_also📖synaptic-vesicle-cycling-neurodegeneration50%
see_also📖DALY Methodology — Neurodegeneration50%
see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N50%
see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration50%
see_also📖Antibody Therapy in Neurodegeneration50%
mentions🧪LRP1-Dependent Tau Uptake Disruption50%
see_also📖RAN Translation in Neurodegeneration50%
see_also📖Neural Circuit Disruption in Neurodegeneration50%
see_also📖SUMOylation in Neurodegeneration50%
see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE45%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime45%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St45%
mentions🧫Parkinson's Disease Subtype Classification — Precision 44%
mentions🧫Prodromal Parkinson's Disease Biomarker Development — E44%
mentions🧫Alpha-Synuclein Seed Amplification Assay Validation44%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset35%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub